Celgene Corp (CELG)
$54.97
-0.78 (-1.40%)
| CAPS Rating |
|
|---|---|
| Open | $53.93 |
| Previous Close | $55.75 |
| Daily Range | $53.72 - $55.68 |
| 52-Week Range | $36.90 - $58.31 |
| Market Cap | $25.26B |
| P/E Ratio | 65.47 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,322,360 |
| Average Daily Volume | 3,694,000 |
CELG
VS S&P 500 (SPY)
How do you think CELG will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
CELG Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
CELG News and Commentary
- Dream Stocks for Biotech Investors – The Motley Fool
- Beware the Second Leg of the Next Great Recession – The Motley Fool
- Get Ready for a 25% Drop – The Motley Fool
- Stocks You Can Be Thankful For – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- The Life-and-Death Situation That Isn't – The Motley Fool
- These Are the Market's 10 Best Stocks – The Motley Fool
- CNBC on Celgene Corp. – Ockham-RazorWire
- Ockham Research on Celgene Corp. – Ockham-RazorWire
- The Easiest Way to Become a Millionaire – The Motley Fool
- Not 50% Growth, but We'll Take It – The Motley Fool
- Should You Have Been in Bonds? – The Motley Fool
- UPDATE 1-Celgene 3rd-qtr profit rises on cancer drug sales – Reuters
- Stock Smackdown: Cramer vs. CAPS – The Motley Fool
- 5-Star Stocks Poised to Pop: KV Pharmaceutical – The Motley Fool
- Onyx Strikes Gold – The Motley Fool
- The Best Stock Idea I've Ever Seen Is No More – The Motley Fool
- US STOCKS SNAPSHOT-Nasdaq turns positive on biotech boost – Reuters
- What Are You Waiting For? – The Motley Fool
- Wall Street's 10 Favorite Stocks Right Now – The Motley Fool
RSS Headlines
Fool UK
